使用事件相关电位分析在表达性语音中实现稳健声音身份识别的基于记忆的训练和测试范式
August 9th, 2024
该研究引入了一种训练测试范式，以研究事件相关电位在置信和可疑韵律场景中的旧/新影响。数据显示，在 Pz 和其他电极处，在 400-850 ms 之间，晚期阳性成分增强。此管道可以探索语音韵律以外的因素及其对线索绑定目标识别的影响。
50 多年来，科学家们一直对我们如何识别声音感到好奇。我们最近的研究探讨了情绪韵律如何影响这个过程。尽管韵律存在差异，但我们发现整体的 old-new 效果是稳健的，这表明我们的大脑始终区分熟悉和不熟悉的声音。
目前说话人识别的实验挑战来自于过去常用的训练测试范式，该范式不适合研究影响说话人身份处理的详细变量。确保培训的全面和有效对于应对这一挑战至关重要。我们的资金显示，虽然 LPC 或旧-新效应显示了置信过程和可疑过程之间的差异，但它总体上仍然稳健。
我们的范例非常适合研究具有内部变化的熟悉和不熟悉对象的处理。我的实验室专注于语音感知，包括如何表达和感知语气标记的情感，以及声音信息如何对听众产生影响。我们使用脑电图和 fMRI 来测量这些因素，重点关注社会因素，例如口音或说话者是否是 AI。这项关于 JoVE 的研究支持了我们未来在这些领域的研究。
概述
本研究通过训练-测试范式调查情感语调如何影响声音识别。研究结果表明了一个强烈的新旧效应，揭示了在自信和怀疑情景中处理的差异。
关键研究组成部分
科学领域
- 神经科学
- 心理学
- 电生理学
背景
- 声音识别已经是一个研究兴趣超过50年的话题。
- 情感语调在区分声音方面扮演重要角色。
- 之前的范式在研究影响说话者身份的详细变量方面存在局限性。
- 彻底的训练对于有效的说话者识别至关重要。
研究目的
- 探索情感语调对声音识别的影响。
- 解决说话者识别方法中的挑战。
- 在不同自信程度下调查新旧效应。
使用的方法
- 测量了事件相关电位（ERPs）。
- 实施了训练-测试范式。
- 参与者接触到各种语调情景。
- 数据分析集中在晚期正分量（LPC）上。
主要结果
- 在400-850毫秒的Pz和其他电极之间观察到增强的晚期正分量。
- 在不同的语调条件下，新旧效应被发现是强烈的。
- 在自信和怀疑的情景中处理的差异被注意到。
- 这种范式可以用来探索影响提示-绑定目标识别的其他因素。
结论
- 情感语调显著影响声音识别过程。
- 训练-测试范式有效地揭示了说话者识别的复杂性。
- 未来的研究可以基于这些发现扩展到包括其他影响因素。
常见问题
Executive Industry Relevance
Robust vocal identity recognition in expressive speech is critical for translational neuroscience and neurotechnology pipelines, especially where cognitive biomarker fidelity impacts early discovery and target validation. This memorization-based ERP paradigm enables real-time, quantitative assessment of speaker-specific cue binding, supporting mechanistic de-risking and predictive confidence in cognitive biomarker research. The approach strengthens portfolio decisions by providing reproducible, high-resolution neural readouts for distinguishing familiar versus unfamiliar vocal stimuli under variable prosodic conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neural mechanisms underlying speaker identity recognition and cue integration.
- Supports functional target validation for cognitive and perceptual biomarkers in neuropsychiatric and neurodegenerative research.
- Facilitates predictive confidence in distinguishing disease-relevant disruptions in voice processing.
Screening & Assay Development
- Provides a validated paradigm for generating quantitative ERP outputs in response to controlled vocal stimuli.
- Standardizes assessment of cognitive processing across expressive speech conditions, supporting assay reproducibility.
- Enables scalable screening of candidate interventions or compounds affecting auditory cognitive pathways.
Translational & Preclinical Research
- Aligns ERP-based cognitive biomarker readouts with disease-relevant endpoints in translational neuroscience.
- Supports continuity from early discovery through preclinical validation of interventions targeting auditory or social cognition.
- De-risks mechanistic ambiguity by linking neural signatures to behavioral discrimination of familiar and unfamiliar voices.
Pipeline & Workflow Integration
This ERP paradigm integrates into the discovery-to-preclinical continuum for cognitive biomarker development and mechanistic neuroscience research.
- Discovery Biology: Quantifies neural correlates of speaker identity recognition and cue binding for hypothesis testing.
- Screening: Delivers reproducible, quantitative ERP outputs for comparing intervention effects on cognitive processing.
- Analytics: Enables statistical analysis of late positive component (LPC) amplitudes and old/new effects across prosodic conditions.
- Translational Research: Bridges discovery findings to preclinical models of phonagnosia and related pathologies.
- Enterprise Reuse: Establishes a reusable, standardized workflow for ERP-based cognitive biomarker assessment in diverse R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cognitive biomarker research.
- Operational Value: Standardizes ERP data acquisition and analysis for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions by providing robust neural readouts for target engagement and biomarker validation.
- Portfolio Impact: Supports risk-adjusted prioritization of cognitive biomarker and neurotechnology assets.
Implementation Considerations
- Requires expertise in EEG/ERP acquisition, preprocessing, and statistical analysis.
- Demands access to high-density EEG systems and compatible analysis software (e.g., RStudio, MATLAB).
- Necessitates rigorous cross-team standardization of training, testing, and data handling protocols.
- Adaptation may be needed for different languages, populations, or disease models.
- Practical limitations include participant compliance and artifact management in EEG recordings.
